As of 2026-09-22, the Intrinsic Value of Athira Pharma Inc (ATHA) is -47.87 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 6.75 USD, the upside of Athira Pharma Inc is -809.21%.
Based on its market price of 6.75 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 809.21%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -47.87 - -47.87 | -47.87 | -809.21% |
| P/E | (76.79) - (121.98) | (104.36) | -1646.1% |
| DDM - Stable | (84.06) - (253.78) | (168.92) | -2602.5% |
| DDM - Multi | (203.56) - (478.97) | (285.82) | -4334.4% |
| Market Cap (mil) | 26.59 |
| Beta | 1.89 |
| Outstanding shares (mil) | 3.94 |
| Enterprise Value (mil) | 26.59 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.68% |
| Cost of Debt | 5.00% |
| WACC | 6.68% |